Similar Papers

Paper Title
Journal
Date
Author
853P - ARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of high and low disease volume and risk groups
A Stenzl ... A.J Armstrong
Annals of Oncology | VOL. 30
A Stenzl, et. al.A Stenzl ... A.J Armstrong
01 Oct 2019
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
...
New England Journal of Medicine | VOL. 389
, et. al. ...
19 Oct 2023
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.
Andrew J Armstrong ... Neal D Shore
Journal of Urology | VOL. 205
Andrew J Armstrong, et. al.Andrew J Armstrong ... Neal D Shore
28 Dec 2020
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
Maha Hussain ... Bettina Noerby
Journal of Urology | VOL. 209
Maha Hussain, et. al.Maha Hussain ... Bettina Noerby
01 Mar 2023
View more papers

More From: Journal of Urology

Paper Title
Journal
Date
Author
Editors’ Choice
D Robert Siemens ... Jonathan C Routh
Journal of Urology | VOL. -
D Robert Siemens, et. al.D Robert Siemens ... Jonathan C Routh
05 Feb 2025
Bruce J. Schlomer, MD
Bruce J Schlomer
Journal of Urology | VOL. 212
Bruce J SchlomerBruce J Schlomer
01 Dec 2024
The Journal of Urology Editor of the Month Article
Kelvin A Moses ... Joseph A Smith
Journal of Urology | VOL. -
Kelvin A Moses, et. al.Kelvin A Moses ... Joseph A Smith
27 Nov 2024
Reviewer of the Month
Meera R Chappidi
Journal of Urology | VOL. -
Meera R ChappidiMeera R Chappidi
08 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.